TNFR1 mRNA expression level and TNFR1 gene polymorphisms are predictive markers for susceptibility to develop invasive pulmonary aspergillosis
Open accessAbstract
Tumour necrosis factor (TNF) is primarily secreted by monocytes/macrophages and activated T lymphocytes in response to fungal infections. TNF acts through TNF receptor 1 (TNFR1) triggering a pro-inflammatory response, and therefore plays a pivotal role in immune regulation and host immune responses. We hypothesized that single nucleotide polymorphisms (SNPs) in TNFR1 gene may influence the innate immune response against Aspergillus. Three SNPs were genotyped in 275 individuals (144 immunocompromised haematological patients with high-risk of developing IPA and 131 healthy controls): TNFR1 -383(A/C) (rs2234649) and TNFR1 -609(G/T) (rs4149570) in the 5′ UTR region, and TNFR1 +36(A/G) SNP (rs767455) in the first exon of the gene. Of the 144 haematological patients, 77 patients developed Invasive Pulmonary Aspergillosis (IPA) infection and the remaining 67 patients were not infected. TNFR1 +36(A/G) and TNFR1 -609(G/T) were associated with IPA susceptibility (p=0.033 and p=0.018, respectively). A role of TNFR1 genetic variants in the susceptibility of patients to develop IPA was also supported by the significantly lower TNFR1 mRNA expression level in IPA than in IPA-resistant patients and the strong correlation between the TNFR1 -609 genetic variant and the expression levels of TNFR1. There was also a tendency for a higher frequency of galactomannan (GM) positivity in patients with TNFR1 -609G/G genotype than in patients with TNFR1 -609G/T (p=0.0909) or TNFR1 -609T/T (p=0.0913) genotype. Predictive sequence analysis of the effects of TNFR1 -609 promoter polymorphism revealed that this SNP might play a critical role in modifying the affinity of ICSBP/IRF-8, a transcription factor that is involved in the TNFR1-mediated activation of NFκB signalling pathway. Taken together, these data suggest that TNFR1 polymorphisms influence the risk of IPA disease and might be useful for risk stratification strategies. These findings need to be confirmed in validation studies with larger samples of haematological patients.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Polymorphisms within the tumor necrosis factor-alpha gene and its receptors are associated with susceptibility to aspergillosis.
“Polymorphisms within the tumor necrosis factor-α (TNF-α) gene [32] and its receptors [37,38] have also been associated with susceptibility to aspergillosis.”
From Race and ethnicity: Risk factors for fungal infections? (2023) · cites this paper as [37]
Cites
Aşçıoğlu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Billé, J., Crokaert, F., Denning, D. W., Donnelly, J. P., Edwards, J. E., Erjavec, Z., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/323335 · Cited by 2,315 · see citing works
TRANSFAC(R) and its module TRANSCompel(R): transcriptional gene regulation in eukaryotes
Matys, V. (2005) · Nucleic Acids Research · doi:10.1093/nar/gkj143 · Cited by 2,142 · see citing works
Quantifying similarity between motifs
Gupta, S., Stamatoyannopoulos, J. A., Bailey, T. L., & Noble, W. S. (2007) · Genome Biology · doi:10.1186/gb-2007-8-2-r24 · Cited by 2,058 · see citing works
IRF Family of Transcription Factors as Regulators of Host Defense
Taniguchi, T., Ogasawara, K., Takaoka, A., & Tanaka, N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.623 · Cited by 1,658 · see citing works
McDermott, M., Aksentijevich, I. A., Galon, J., McDermott, E. M., Ogunkolade, B.-W., Centola, M. B., Mansfield, E. A., Gadina, M., Karenko, L., Pettersson, T., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80721-7 · Cited by 1,404 · see citing works
Hehlgans, T., & Pfeffer, K. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02143.x · Cited by 1,049 · see citing works
Tartaglia, L. A., & Goeddel, D. V. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90116-o · Cited by 1,043 · see citing works
Marr, K. A., Carter, R. A., Boeckh, M., Martin, P., & Corey, L. (2002) · Blood · doi:10.1182/blood-2002-05-1496 · Cited by 957 · see citing works
The −308 tumor necrosis factor-α promoter polymorphism effects transcription
Kroeger, K. M., Carville, K. S., & Abraham, L. J. (1997) · Molecular Immunology · doi:10.1016/s0161-5890(97)00052-7 · Cited by 870 · see citing works
Chamilos, G., Luna, M. A., Lewis, R. E., Bodey, G. P., Chemaly, R. F., Tarrand, J. J., Safdar, A., RAAD, I. I., & Kontoyiannis, D. P. (2006) · PubMed · Cited by 479 · see citing works
Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation
Bochud, P.-Y., Chien, J. W., Marr, K. A., Leisenring, W. M., Upton, A., Janer, M., Rodrigues, S. D., Li, S., Hansen, J. A., Zhao, L. P., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802629 · Cited by 453 · see citing works
Marks, J. D., Marks, C. B., Ljuce, J. M., Montgomery, A. B., Turner, J., Metz, C. A., & Murray, J. F. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/141.1.94 · Cited by 329 · see citing works
ICSBP Directs Bipotential Myeloid Progenitor Cells to Differentiate into Mature Macrophages
Tamura, T., Nagamura-Inoue, T., Shmeltzer, Z., Kuwata, T., & Ozato, K. (2000) · Immunity · doi:10.1016/s1074-7613(00)00016-9 · Cited by 305 · see citing works
Role of TNF-alpha in pulmonary host defense in murine invasive aspergillosis.
Mehrad, B., Strieter, R. M., & Standiford, T. J. (1999) · PubMed · Cited by 264 · see citing works
Cytokine‐ and T Helper–Dependent Lung Mucosal Immunity in Mice with Invasive Pulmonary Aspergillosis
Cenci, E., Mencacci, A., d’Ostiani, C. F., Sero, G. D., Mosci, P., Montagnoli, C., Bacci, A., & Romani, L. R. (1998) · The Journal of Infectious Diseases · doi:10.1086/314493 · Cited by 253 · see citing works
Regulatory polymorphisms underlying complex disease traits.
Knight, J. C. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0603-7 · Cited by 246 · see citing works
Cumberbatch, M., & Kimber, I. (1995) · PubMed Central · Cited by 245 · see citing works
Role of TNF-α in Pulmonary Host Defense in Murine Invasive Aspergillosis
Mehrad, B., Strieter, R. M., & Standiford, T. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.3.1633 · Cited by 244 · see citing works
Th1 and Th2 cytokines in mice with invasive aspergillosis
Cenci, E., Perito, S., Enssle, K.-H., Mosci, P., Latgé, J., Romani, L. R., & Bistoni, F. (1997) · Infection and Immunity · doi:10.1128/iai.65.2.564-570.1997 · Cited by 216 · see citing works
Kollias, G. A., Douni, E. K., Kassiotis, G., & Kontoyiannis, D. L. (1999) · Annals of the Rheumatic Diseases · doi:10.1136/ard.58.2008.i32 · Cited by 210 · see citing works
Impact of Previous Aspergillosis on the Outcome of Bone Marrow Transplantation
Offner, F. C., Cordonnier, C., Ljungman, P. T., Prentice, H. G., Engelhard, D., Bacquer, D. D., Meunier, F., & de Pauw, B. (1998) · Clinical Infectious Diseases · doi:10.1086/520274 · Cited by 181 · see citing works
Interferon- and Tumor Necrosis Factor- Protect Mice from Invasive Aspergillosis
Nagai, H., Guo, J., Choi, H., & Kurup, V. P. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/172.6.1554 · Cited by 173 · see citing works
Ferrante, A. (1989) · Infection and Immunity · doi:10.1128/iai.57.7.2115-2122.1989 · Cited by 168 · see citing works
Jones, S. J., Ledgerwood, E. C., Prins, J. B., Galbraith, J., Johnson, D. R., Pober, J. S., & Bradley, J. R. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.2.1042 · Cited by 160 · see citing works
Zhao, J., Kong, H. J., Li, H., Huang, B., Yang, M., Zhu, C. Y., Bogunovic, M., Zheng, F., Mayer, L., Ozato, K., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m507788200 · Cited by 140 · see citing works
Duong, M., Ouellet, N., Simard, M., Bergeron, Y., Olivier, M., & Bergeron, M. G. (1998) · The Journal of Infectious Diseases · doi:10.1086/314425 · Cited by 120 · see citing works
Science, medicine, and the future: Susceptibility to infection
Kwiatkowski, D. P. (2000) · BMJ · doi:10.1136/bmj.321.7268.1061 · Cited by 89 · see citing works
Sainz, J., Pérez, E., Gómez-Lopera, S., & Jurado, M. (2008) · Journal of Clinical Immunology · doi:10.1007/s10875-008-9197-0 · Cited by 84 · see citing works
Self-citationInterleukin-10 promoter polymorphism as risk factor to develop invasive pulmonary aspergillosis
Sáinz, J., Hassan, L., Perez, E., Romero, A., Moratalla, A., López‐Fernández, E., Oyonarte, S., & Jurado, M. (2007) · Immunology Letters · doi:10.1016/j.imlet.2007.01.005 · Cited by 81 · see citing works
Self-citationSainz, J., Pérez, E., Hassan, L., Moratalla, A., Romero, A., Collado, M. D., & Jurado, M. (2007) · Human Immunology · doi:10.1016/j.humimm.2006.10.011 · Cited by 81 · see citing works
Self-citationIdentification of IRF-8 and IRF-1 target genes in activated macrophages
Dror, N., Alter-Koltunoff, M., Azriel, A., Amariglio, N., Jacob‐Hirsch, J., Zeligson, S., Morgenstern, A., Tamura, T., Häuser, H., Rechavi, G., et al. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.02.026 · Cited by 79 · see citing works
Wu‐Hsieh, B. A., Lee, G. S., Franco, M. P., et al. (1992) · Infection and Immunity · doi:10.1128/iai.60.10.4230-4238.1992 · Cited by 77 · see citing works
Netea, M. G., Blok, W. L., Kullberg, B. J., et al. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.2.393 · Cited by 69 · see citing works
Rosa, G. R. D. L., Champlin, R. E., & Kontoyiannis, D. P. (2002) · Transplant Infectious Disease · doi:10.1034/j.1399-3062.2002.00010.x · Cited by 67 · see citing works
Waschke, K. A., Villani, A., Vermeire, S., Dufresne, L., Chen, T.-C., Bitton, A., Cohen, A., Thomson, A. B. R., & Wild, G. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.40534.x · Cited by 67 · see citing works
Nishimura, M., Obayashi, H., Mizuta, I., Hara, H., Adachi, T., Ohta, M., Tegoshi, H., Fukui, M., Hasegawa, G., Shigeta, H., et al. (2003) · Human Immunology · doi:10.1016/s0198-8859(02)00799-1 · Cited by 52 · see citing works
Wang, S., Wei, M., Han, Y., et al. (2008) · BMC Infectious Diseases · doi:10.1186/1471-2334-8-27 · Cited by 50 · see citing works
Sáinz, J., Pérez, E., Gómez-Lopera, S., López‐Fernández, E., Moratalla, L., Oyonarte, S., & Jurado, M. (2008) · Cytokine · doi:10.1016/j.cyto.2007.11.018 · Cited by 28 · see citing works
Self-citationExpression of tumor necrosis factor alpha and its receptors during cellular differentiation
Schling, P., Rudolph, C., Heimerl, S., Fruth, S., & Schmitz, G. (2006) · Cytokine · doi:10.1016/j.cyto.2006.02.007 · Cited by 26 · see citing works
An MspA1 I polymorphism in exon 1 of the human TNF receptor type I (p55) gene.
Pitts, S. A., Olomolaiye, O. O., Elson, C. J., et al. (1998) · PubMed · Cited by 24 · see citing works
Pitts, S. A., Olomolaiye, O. O., Elson, C. J., et al. (1998) · European Journal of Immunogenetics · doi:10.1111/j.1744-313x.1998.tb01149.x · Cited by 20 · see citing works
Luther, K., Rohde, M., Heesemann, J., & Ebel, F. (2006) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2005.11.008 · Cited by 15 · see citing works
An MspA1 I polymorphism in exon 1 of the human TNF receptor type I (p55) gene
Pitts, S. A., Olomolaiye, O. O., Elson, C. J., et al. (1998) · European Journal of Immunogenetics · doi:10.1111/j.1744-313x.1998.tb01148.x · Cited by 7 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Romani, L. (2011) · Nature Reviews Immunology · doi:10.1038/nri2939 · Cited by 1,793 · see citing works
Race and ethnicity: Risk factors for fungal infections?
Jenks, J. D., Aneke, C. I., Al-Obaidi, M. M., Egger, M., Garcia, L., Gaines, T., Hoenigl, M., & Thompson, G. R. (2023) · PLOS Pathogens · doi:10.1371/journal.ppat.1011025 · Cited by 55 · see citing works
Lupiañez, C. B., Canet, L. M., Carvalho, A., Alcazar-Fuoli, L., Springer, J., Lackner, M., Segura-Catena, J., Comino, A., Olmedo, C., Ríos, R., et al. (2016) · Infection and Immunity · doi:10.1128/iai.01359-15 · Cited by 42 · see citing works
Self-citation
- Authors
- Sainz, J., Salas-Alvarado, I., López-Fernández, E., Olmedo, C., Comino, A., García, F., Blanco, A., Gómez-Lopera, S., Oyonarte, S., Bueno, P., & Jurado, M.
- Affiliations
- Experimental Research Unit, Virgen de las Nieves University Hospital, Granada
- Hospital Universitario Virgen de las Nieves (ES)
- Haematology Department, Virgen de las Nieves University Hospital, Granada
- Universidad de Granada (ES)
- Blood Transfusion Centre and Tissue Bank of Granada and Almeria, Spain
- Venue
- International Journal of Immunopathology and Pharmacology
- Publisher
- SAGE Publications
- Published
- 2010-04
- Volume
- 23
- Issue
- 2
- Pages
- 423-436
- ISSN
- 0394-6320 (ISSN-L)
- 2058-7384
- OpenAlex
- W4848550
- Cited by
- 56
- References
- 43
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 3 · 2022: 4 · 2021: 2 · 2020: 8 · 2019: 2 · 2018: 1 · 2017: 3 · 2016: 3 · 2015: 4 · 2014: 5 · 2013: 4 · 2012: 1
- FWCI
- 3.93
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- International Journal of Immunopathology and Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Instituto de Salud Carlos III
- Dirección General de Investigación Científica y Técnica
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Keywords
- TNFR1, TNF receptor 1, invasive pulmonary aspergillosis, single nucleotide polymorphisms, genetic susceptibility, hematologic patients, immunocompromised patients, promoter polymorphism, galactomannan, NF-κB signaling, innate immune response, Aspergillus
- MeSH terms
- Interferon Regulatory Factor-8, Aspergillosis, Female, Galactose, Humans, Lung Diseases, Fungal, Male, Mannans, RNA, Messenger, Biomarkers, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Receptors, Tumor Necrosis Factor, Type I, Interferon Regulatory Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review